Prostate Cancer News Today provided readers with daily coverage of important discoveries, potential blood tests and disease markers, as well as treatment developments related to prostate cancer during 2018. We look forward to reporting more news to patients, family members and caregivers during 2019. Here are the Top 10 most-read stories of 2018, with a brief description of what made them interesting for the prostate cancer community. radiation therapy. HIFU, which removes the diseased tissue only, also led to absence of cancer tissue in the targeted area as assessed via biopsy. However, scores of urinary symptoms and quality of life went back to baseline 3-6 months after HIFU in 78% of patients. Also, 85% of patients maintained erectile function, while 15% had erectile dysfunction at 12 months.